Hepatitis C
📧 Sign up to get email alerts when something new happens for Hepatitis C.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2017-03-20Clinical Trial Update: A Study of Viral Response to Triple Therapy in Hepatitis C Virus-Infected Participants With Insulin Resistance Who Failed Dual Therapy (MK-3034-113) [Phase 4]
Phase 4 trial MK-3034-113 investigating triple therapy for Hepatitis C in insulin-resistant patients who failed dual therapy has been withdr…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Civacir® Polyclonal Immune Globulin (IgG) to Prevent Hepatitis C Virus (HCV) Recurrence in Liver Transplant Patients. [Phase 3]
Phase 3 trial update of Civacir, a polyclonal IgG, to prevent hepatitis C virus recurrence in liver transplant patients; study status is com…
-
CLINICAL_TRIALS trial_result · 2017-03-15Clinical Trial Update: Comparative Effectiveness and Tolerability of Boceprevir vs Telaprevir [NA]
A completed clinical trial comparing the effectiveness and tolerability of Boceprevir versus Telaprevir in adults with chronic hepatitis C a…
-
CLINICAL_TRIALS research · 2017-03-15Clinical Trial Update: Quality of Life Therapy for Adults With Hepatitis C Virus and Cirrhosis Awaiting Liver Transplantation [NA]
A completed clinical trial evaluated a quality-of-life therapy for adults with chronic hepatitis C and liver cirrhosis awaiting transplantat…
-
CLINICAL_TRIALS trial_result · 2017-03-14Clinical Trial Update: Safety Study of the Aethlon Hemopurifier [NA]
Safety study of the Aethlon Hemopurifier has been terminated. It targeted patients with End-stage renal disease and Hepatitis C infection.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Effect of Low-dose PegIntron on ALT Normalization in Japanese Patients With Chronic Hepatitis C (Study P04508)(COMPLETED) [Phase 2]
A completed Phase 2 trial evaluating whether low-dose PegIntron promotes ALT normalization in Japanese patients with chronic hepatitis C. Th…
-
CLINICAL_TRIALS trial_result · 2017-03-13Clinical Trial Update: Inhibition of Disease Progression in Hepatitis C-infected Patients With Compensated Liver Cirrhosis (P03811) (COMPLETED) [Phase 3]
A Phase 3 clinical trial evaluating inhibition of disease progression in hepatitis C patients with compensated liver cirrhosis was completed…
-
CLINICAL_TRIALS trial_result · 2017-03-08Clinical Trial Update: CPG10101 Combination Therapy For The Treatment Of Hepatitis C In Non-Responder (Null And Partial Responder) Hepatitis C Virus (HCV) Genotype 1 Infected Subjects [Phase 2]
Phase 2 trial update evaluating CPG10101 in combination therapy for chronic hepatitis C genotype 1 in non-responders, with the study status …
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Regression of Liver Fibrosis After Daclatasvir and Asunaprevir Treatment
A clinical trial update reports regression of liver fibrosis in patients with chronic hepatitis C treated with daclatasvir and asunaprevir.
-
CLINICAL_TRIALS trial_result · 2017-03-07Clinical Trial Update: Comparative Assessment of Utilization of Antiviral Therapies in Hepatitis C and Effectiveness of Daclatasvir-containing Regimens in Real-life Clinical Care in Europe (CMPASS-EU)
This clinical trial update assesses real-world use of antiviral therapies for hepatitis C in Europe. It also evaluates the effectiveness of …
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Sofosbuvir and Simeprevir Versus Sofosbuvir and Ribavirin in Treatment of HCV [Phase 4]
Phase 4 trial comparing Sofosbuvir plus Simeprevir to Sofosbuvir plus Ribavirin for Hepatitis C has completed.
-
CLINICAL_TRIALS trial_result · 2017-03-03Clinical Trial Update: Telaprevir With Peginterferon Alfa & Ribavirin in Ex-People Who INject Drugs Infected by Genotype 1 Chronic Hepatitis C
A completed clinical trial assessing telaprevir in combination with peginterferon alfa and ribavirin for genotype 1 chronic hepatitis C in i…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Study to Assess Efficacy, Safety, Tolerability and Pharmacokinetics of Simeprevir, Daclatasvir and Sofosbuvir in Treatment-naive Participants With Chronic Hepatitis C Virus Genotype 1 Infection [Phase 2]
Phase 2 trial evaluating the efficacy, safety, tolerability, and pharmacokinetics of a triple-drug regimen (simeprevir, daclatasvir, sofosbu…
-
CLINICAL_TRIALS trial_result · 2017-03-01Clinical Trial Update: Chronic Hepatitis Intervention Project for Drug Users [Phase 3]
A Phase 3 clinical trial evaluating a chronic hepatitis intervention for drug users has completed, sponsored by NIDA, with conditions includ…
-
CLINICAL_TRIALS trial_result · 2017-02-28Clinical Trial Update: Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed-Dose Combination (FDC) for 6 Weeks in Adults With Acute Genotype 1 or 4 Hepatitis C Virus (HCV) and Chronic Human Immunodeficiency Virus (HIV)-1 Co-Infection [Phase 2]
Phase 2 trial assessing the safety and efficacy of a 6-week Ledipasvir/Sofosbuvir regimen in adults with acute HCV genotype 1 or 4 and HIV c…
-
CLINICAL_TRIALS trial_result · 2017-02-24Clinical Trial Update: Dynamic Changes of Monocytes and NK Cells of CHC Patient Treated by DAAs
This clinical trial update reports dynamic changes in monocytes and natural killer cells in a chronic hepatitis C patient treated with direc…
-
CLINICAL_TRIALS research · 2017-02-23Clinical Trial Update: Treatment of Hepatitis C Virus Infection With Generic Sofosbuvir/Ledipasvir in Iranian Patients [Phase 3]
A Phase 3 clinical trial in Iran is evaluating generic sofosbuvir/ledipasvir for hepatitis C, with no current status or results reported.
-
CLINICAL_TRIALS trial_result · 2017-02-20Clinical Trial Update: Pilot Feasibility Study of a Cognitive Behavioral Coping Skills (CBCS) Group Intervention for Hep C Therapy Patients [NA]
This document reports the completion of a pilot feasibility trial evaluating a cognitive behavioral coping skills group intervention for pat…
-
CLINICAL_TRIALS trial_result · 2017-02-16Clinical Trial Update: 3-year Follow-up Study in Patients Previously Treated With TMC435-Containing Regimen for the Treatment of Hepatitis C Virus Infection [Phase 3]
Three-year follow-up results from a Phase 3 study in hepatitis C patients previously treated with a TMC435-containing regimen, reporting lon…
-
CLINICAL_TRIALS research · 2017-02-16Clinical Trial Update: Reviewing DAA Efficacy Managing Patient Treatment In Online Neighbourhoods
A clinical trial update discussing ongoing assessment of direct-acting antivirals for hepatitis C and patient management in online communiti…
-
FDA approval · 2017-02-14FDA Approved: EPCLUSA — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for Epclusa (sofosbuvir/velpatasvir) submitted by Gilead Sciences, Inc., indicating an extension…
-
FDA approval · 2017-02-14FDA Approved: LEDIPASVIR AND SOFOSBUVIR — Supplemental Application (Asegua Therapeutics LLC)
FDA approved a supplemental application for ledipasvir and sofosbuvir from Asegua Therapeutics LLC.
-
CLINICAL_TRIALS trial_result · 2017-02-14Clinical Trial Update: Safety and Efficacy of Ledipasvir/Sofosbuvir (LDV/SOF) Fixed Dose Combination Tablet With Ribavirin for 12 Weeks in Treatment-naive Adults With Chronic HCV Genotype 3 Infection [Phase 2]
Phase 2 trial evaluating safety and efficacy of a ledipasvir/sofosbuvir fixed-dose combination tablet with ribavirin for 12 weeks in treatme…
-
FDA approval · 2017-02-14FDA Approved: SOVALDI — Supplemental Application (Gilead Sciences, Inc.)
The FDA approved a supplemental application for Sovaldi (sofosbuvir) submitted by Gilead Sciences, Inc. The decision pertains to hepatitis C…
-
CLINICAL_TRIALS trial_result · 2017-02-13Clinical Trial Update: An Efficacy, Safety and Pharmacokinetics Study of Simeprevir, Daclatasvir and Sofosbuvir in Participants With Chronic Hepatitis C Virus Genotype 1 or 4 Infection and Decompensated Liver Disease [Phase 2]
A Phase 2 trial assessed the efficacy, safety, and pharmacokinetics of a three-drug regimen—simeprevir, daclatasvir, and sofosbuvir—in adult…